Paper32336655
Policy- and county-level associations with HIV pre-exposure prophylaxis use, the United States, 2018.
Siegler AJ and 11 others. Ann Epidemiol, 2020. Cited by 80 papers, by iCite.
Cite this record
ConductScience Library. Policy- and county-level associations with HIV pre-exposure prophylaxis use, the United States, 2018. Papers, record 32336655. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32336655
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Policy- and county-level associations with HIV pre-exposure prophylaxis use, the United States, 2018.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-HIV Agents | Major topic |
| HIV Infections | Major topic |
| Medicaid | Major topic |
| Policy Making | Major topic |
| Pre-Exposure Prophylaxis | Major topic |
| Adult | |
| Aged | |
| Female | |
| Health Policy | |
| Humans | |
| Local Government | |
| Male | |
| Middle Aged | |
| Residence Characteristics | |
| United States |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P30 AI050409 | NIAID NIH HHS | United States | P30AI050409 | PubMed and NIH | NIH RePORTER |
| R01 AI143875 | NIAID NIH HHS | United States | R01AI143875 | PubMed and NIH | NIH RePORTER |
| U19 HD089881 | NICHD NIH HHS | United States | U19HD089881 | PubMed and NIH | NIH RePORTER |
| R01 MH114692 | NIMH NIH HHS | United States | R01MH114692 | PubMed and NIH | NIH RePORTER |
| P30 AI060354 | NIAID NIH HHS | United States | P30AI060354 | PubMed | NIH RePORTER |
References22
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28558067 | Impact of insurance coverage on utilization of pre-exposure prophylaxis for HIV prevention. | PLoS One | 2017 | https://conductscience.org/library/papers/28558067 | PubMed |
| 2 | 27302837 | Retention in care outcomes for HIV pre-exposure prophylaxis implementation programmes among men who have sex with men in three US cities. | J Int AIDS Soc | 2016 | https://conductscience.org/library/papers/27302837 | PubMed |
| 3 | 31298662 | Changes in HIV Preexposure Prophylaxis Awareness and Use Among Men Who Have Sex with Men - 20 Urban Areas, 2014 and 2017. | MMWR Morb Mortal Wkly Rep | 2019 | https://conductscience.org/library/papers/31298662 | PubMed |
| 4 | 30775846 | Persistence on HIV preexposure prophylaxis medication over a 2-year period among a national sample of 7148 PrEP users, United States, 2015 to 2017. | J Int AIDS Soc | 2019 | https://conductscience.org/library/papers/30775846 | PubMed |
| 5 | 26537525 | The Impact of State AIDS Drug Assistance Policies on Clinical and Economic Outcomes of People With HIV. | Med Care Res Rev | 2016 | https://conductscience.org/library/papers/26537525 | PubMed |
| 6 | 31177363 | Implementation Strategies to Increase PrEP Uptake in the South. | Curr HIV/AIDS Rep | 2019 | https://conductscience.org/library/papers/31177363 | PubMed |
| 7 | 31318587 | Geographic Access to Preexposure Prophylaxis Clinics Among Men Who Have Sex With Men in the United States. | Am J Public Health | 2019 | https://conductscience.org/library/papers/31318587 | PubMed |
| 8 | 26898645 | Successful Implementation of HIV Preexposure Prophylaxis: Lessons Learned From Three Clinical Settings. | Curr HIV/AIDS Rep | 2016 | https://conductscience.org/library/papers/26898645 | PubMed |
| 9 | 26967306 | Public Health-Seattle & King County and Washington State Department of Health Preexposure Prophylaxis Implementation Guidelines, 2015. | Sex Transm Dis | 2016 | https://conductscience.org/library/papers/26967306 | PubMed |
| 10 | 27418048 | Impact of the Centers for Disease Control's HIV Preexposure Prophylaxis Guidelines for Men Who Have Sex With Men in the United States. | J Infect Dis | 2016 | https://conductscience.org/library/papers/27418048 | PubMed |
| 11 | 26370101 | A SWOT Analysis of the Updated National HIV/AIDS Strategy for the U.S., 2015-2020. | AIDS Behav | 2016 | https://conductscience.org/library/papers/26370101 | PubMed |
| 12 | 32088073 | Methods for county-level estimation of pre-exposure prophylaxis coverage and application to the U.S. Ending the HIV Epidemic jurisdictions. | Ann Epidemiol | 2020 | https://conductscience.org/library/papers/32088073 | PubMed |
| 13 | 26606148 | Vital Signs: Estimated Percentages and Numbers of Adults with Indications for Preexposure Prophylaxis to Prevent HIV Acquisition--United States, 2015. | MMWR Morb Mortal Wkly Rep | 2015 | https://conductscience.org/library/papers/26606148 | PubMed |
| 14 | 30343026 | Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study. | Lancet HIV | 2018 | https://conductscience.org/library/papers/30343026 | PubMed |
| 15 | 29983236 | The prevalence of pre-exposure prophylaxis use and the pre-exposure prophylaxis-to-need ratio in the fourth quarter of 2017, United States. | Ann Epidemiol | 2018 | https://conductscience.org/library/papers/29983236 | PubMed |
| 16 | 27851714 | Preexposure Prophylaxis for HIV Prevention in a Large Integrated Health Care System: Adherence, Renal Safety, and Discontinuation. | J Acquir Immune Defic Syndr | 2016 | https://conductscience.org/library/papers/27851714 | PubMed |
| 17 | 30406756 | Location location location: an exploration of disparities in access to publicly listed pre-exposure prophylaxis clinics in the United States. | Ann Epidemiol | 2018 | https://conductscience.org/library/papers/30406756 | PubMed |
| 18 | 24260137 | Association between U.S. state AIDS Drug Assistance Program (ADAP) features and HIV antiretroviral therapy initiation, 2001-2009. | PLoS One | 2013 | https://conductscience.org/library/papers/24260137 | PubMed |
| 19 | 25065857 | Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study. | Lancet Infect Dis | 2014 | https://conductscience.org/library/papers/25065857 | PubMed |
| 20 | 23797289 | The state of engagement in HIV care in the United States: from cascade to continuum to control. | Clin Infect Dis | 2013 | https://conductscience.org/library/papers/23797289 | PubMed |
Cited by58
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 80 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42658858 | Enhancing uptake of PrEP for her via organizational research and individual actions (EUPHORIA): Protocol for a stepped-wedge cluster randomized trial. | PLoS One | 2026 | https://conductscience.org/library/papers/42658858 | PubMed |
| 42427078 | What Tools Do We Have to End the US HIV Epidemic? A Review of Structural, Biomedical and Implementation Interventions and Their Potential Population Impact. | J Int AIDS Soc | 2026 | https://conductscience.org/library/papers/42427078 | PubMed |
| 41617214 | Establish a PrEP (Pre-Exposure Prophylaxis) Epidemiology, Modeling, and Surveillance (PREMISE) System to Analyze Trends in PrEP Uptake and the Impact of PrEP Programs and Policies: Protocol for a Natural Experiment and Modeling Study in the United States. | JMIR Res Protoc | 2026 | https://conductscience.org/library/papers/41617214 | PubMed |
| 41396185 | HIV Diagnosis and Preexposure Prophylaxis (PrEP) Prescription Among Commercially Insured Persons With Bipolar Disorder. | J Clin Psychiatry | 2025 | https://conductscience.org/library/papers/41396185 | PubMed |
| 41324957 | Telemedicine Preexposure Prophylaxis Prescribing From a Large Online US Company. | JAMA Netw Open | 2025 | https://conductscience.org/library/papers/41324957 | PubMed |
| 41223030 | Pre-Exposure prophylaxis knowledge, use and adherence among a US national sample of women. | AIDS Care | 2026 | https://conductscience.org/library/papers/41223030 | PubMed |
| 41052386 | Impact Of Medicaid Expansion On HIV Pre-Exposure Prophylaxis Coverage, 2012-23. | Health Aff (Millwood) | 2025 | https://conductscience.org/library/papers/41052386 | PubMed |
| 40932715 | Excess HIV Infections and Costs Associated With Reductions in HIV Prevention Services in the US. | JAMA Netw Open | 2025 | https://conductscience.org/library/papers/40932715 | PubMed |
| 40816951 | Impacts of Medicaid Expansion on Contraceptive Use Among Women in Neighborhoods of Racialized Socioeconomic Deprivation in the United States. | Womens Health Issues | 2025 | https://conductscience.org/library/papers/40816951 | PubMed |
| 40719963 | What Is the Effect of Medicaid Expansions on Preexposure Prophylaxis for HIV Prevention Use among Women? | AIDS Behav | 2025 | https://conductscience.org/library/papers/40719963 | PubMed |
| 40617367 | Mortgage discrimination at the intersection of race and sexual orientation and its association with HIV incidence among sexual minority men in the U.S. | Ann Epidemiol | 2025 | https://conductscience.org/library/papers/40617367 | PubMed |
| 40600487 | Leveraging existing market incentives to increase HIV pre-exposure prophylaxis access in the United States. | J Int AIDS Soc | 2025 | https://conductscience.org/library/papers/40600487 | PubMed |
| 40364537 | Inequities in PrEP annualized pill-day coverage, United States, 2018-2022: a cross-sectional pharmacoequity analysis. | J Int AIDS Soc | 2025 | https://conductscience.org/library/papers/40364537 | PubMed |
| 40199238 | Trends in HIV Preexposure Prophylaxis Use Before and After Launch of the Ending the HIV Epidemic in the US Initiative, 2016-2023. | J Acquir Immune Defic Syndr | 2025 | https://conductscience.org/library/papers/40199238 | PubMed |
| 39781235 | The prevalence of HIV pre-exposure prophylaxis (HIV-PrEP) use and HIV-PrEP-to-need ratio in nine Canadian provinces, 2018-2021. | Can Commun Dis Rep | 2025 | https://conductscience.org/library/papers/39781235 | PubMed |
| 39739278 | County-Level Factors Associated with Reversal of Insurer-Approved HIV Pre-Exposure Prophylaxis Prescriptions in the United States, 2018. | AIDS Behav | 2025 | https://conductscience.org/library/papers/39739278 | PubMed |
| 39734803 | Disparities in PrEP use and unmet need across PEPFAR-supported programs: doubling down on prevention to put people first and end AIDS as a public health threat by 2030. | Front Reprod Health | 2024 | https://conductscience.org/library/papers/39734803 | PubMed |
| 39628794 | Where do we go from here? Reconciling implementation failure of PrEP for Black women in the South. Leveraging critical realism to identify unaddressed barriers as we move forward. | Front Reprod Health | 2024 | https://conductscience.org/library/papers/39628794 | PubMed |
| 39556546 | PrEP your step: Implementing an online crowdsourcing contest to engage young people in HIV prevention in Washington DC, USA. | PLoS One | 2024 | https://conductscience.org/library/papers/39556546 | PubMed |
| 39141024 | Claims-Based Algorithm to Identify Pre-Exposure Prophylaxis Indications for Tenofovir Disoproxil Fumarate and Emtricitabine Prescriptions (2012-2014): Validation Study. | JMIR Form Res | 2024 | https://conductscience.org/library/papers/39141024 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32336655
GET https://conductscience.org/api/papers/v1/32336655/references?page=2